Compile Data Set for Download or QSAR
Report error Found 128 Enz. Inhib. hit(s) with all data for entry = 2374
TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362932(US9850203, Compound 1-1 | 3-((6-Chloro-7-fluoro-1-...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362938(US9850203, Compound 1-5 | 2-(6-Chloro-7-fluoro-2-m...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362939(US9850203, Compound 1-6 | 3-((6-Chloro-7-fluoro-2-...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362940(US9850203, Compound 1-7 | 3-((6-Chloro-1-(2-(dimet...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362942(US9850203, Compound 1-9 | 3-((6-Chloro-7-fluoro-2-...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362943(US9850203, Compound 1-10 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362945(US9850203, Compound 1-12 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362946(US9850203, Compound 1-13 | 3-((6-Chloro-1-(2-(4-((...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362947(US9850203, Compound 1-14 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362949(US9850203, Compound 1-16 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362951(US9850203, Compound 1-18 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362952(US9850203, Compound 1-19 | 3-((6-Chloro-1-(2-(2-cy...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362953(US9850203, Compound 1-20 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362954(US9850203, Compound 1-21 | US9850203, Compound 1-6...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362955(US9850203, Compound 1-22 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362956(US9850203, Compound 1-24 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362957(US9850203, Compound 1-25 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362958(US9850203, Compound 1-26 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362959(US9850203, Compound 1-31 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362960(US9850203, Compound 1-32 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362961(US9850203, Compound 1-33 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362962(US9850203, Compound 1-34 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362963(US9850203, Compound 1-35 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362964(US9850203, Compound 1-36 | 3-((6-Chloro-1-(2-(3,4-...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362965(US9850203, Compound 1-37 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362966(US9850203, Compound 1-38 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362967(US9850203, Compound 1-39 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362969(US9850203, Compound 1-41 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362970(US9850203, Compound 1-42 | 3-((6-Chloro-1-(2-(3-(3...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362971(US9850203, Compound 1-44 | 3-((6-Chloro-1-(2-(4,4-...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362972(US9850203, Compound 1-45 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362973(US9850203, Compound 1-46 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362974(US9850203, Compound 1-48 | 3-((6-Chloro-1-(2-(3-(1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362975(US9850203, Compound 1-49 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362976(US9850203, Compound 1-50 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362977(US9850203, Compound 1-51 | 3-((1-(2-((1R,5S,6R)-6-...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362978(US9850203, Compound 1-52 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362979(US9850203, Compound 1-53 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362980(US9850203, Compound 1-58 | 3-((6-Chloro-1-(2-(5-me...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362983(US9850203, Compound 1-61 | 3-((1-(2-(4-(2-(1H-Pyra...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362985(US9850203, Compound 1-63 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362986(US9850203, Compound 1-64 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362954(US9850203, Compound 1-21 | US9850203, Compound 1-6...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362990(US9850203, Compound 1-68 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362991(US9850203, Compound 1-69 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362992(US9850203, Compound 1-70 | 3-((6-Chloro-1-(2-(4,6-...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362993(US9850203, Compound 1-71 | 3-((6-Chloro-1-(2-(5-ch...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362995(US9850203, Compound 1-73 | 3-((6-Chloro-1-(2-(6-ch...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362953(US9850203, Compound 1-20 | 3-((6-Chloro-7-fluoro-1...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandPNGBDBM362999(US9850203, Compound 1-77 | 3-((6-Chloro-7-fluoro-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2019
Entry Details
Go to US Patent

Displayed 1 to 50 (of 128 total ) | Next | Last >>
Jump to: